Abstract Submission
Retina Futura Late Breakers
There are only few slots still available in Retina Futura Sessions: we are thus inviting you to submit an abstract if you wish to present on the latest cutting-edge research and innovative clinical approaches shaping the future of retinal care.
We welcome submissions covering a range of topics, including but not limited to:
- Novel therapies for retinal diseases
- Advances in gene therapy, cell therapy, and regenerative medicine
- Ongoing clinical trial results and updates.
Selected abstracts will be featured in Retina Futura sessions, and authors will have the opportunity to present their work to leading experts and peers in the field.
Submission Guidelines:
- Deadline: November 2nd, 2024
- Please include a brief description of your research, key findings, and potential impact on clinical practice.
Submit your abstract today and be part of this exciting opportunity to contribute to the future of retinal research and care!
For more information, please visit the Congress Website or contact the Organizing Secretariat (Riccardo Iannantuoni - A.P. Meetings: riccardo.iannantuoni@apmeetings.com).
Retina Futura Clinical Trial Symposium
We are also offering opportunities for biopharmaceutical companies to present their ongoing or planned clinical trials that are relevant to our global audience but specifically to the European healthcare ecosystem. This is a unique opportunity to showcase your groundbreaking research and developments that have not yet been introduced in Europe.
By presenting in the Clinical Trial Symposium (link da Anna) you will have the chance to:
- Connect with leading experts, regulators, and stakeholders in the European and global healthcare sectors;
- Highlight your innovative approaches to unmet medical needs;
- Explore potential collaborations and partnerships in the European market;
- Gain visibility among key opinion leaders and decision-makers.
We would be honored to feature your work in this exclusive forum and look forward to the opportunity of including your insights in the program!
For more information, please visit the Congress Website or contact Ms Didi Discard (didi.discar@retinafutura.com).